Chengdu Shiji Biopharmaceutical Co., Ltd. announced that it will receive CNY 60,000,000 in its equity round of funding on August 2, 2023. The transaction includes participation from existing investors, from Liaoning Chengda Biotechnology Co.,Ltd. for CNY 18,000,000 and to retain its 30% stake and Infund Holding Co., Ltd. for CNY 42,000,000 and 70% stake in the company. The transaction has been reviewed and approved at the third meeting of the fifth board of directors held by the investor and does not need to be submitted to the company's shareholders' meeting.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.86 CNY | +4.88% | -5.49% | -72.78% |
May. 12 | Infund Holding Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares. | CI |
May. 11 | Infund Holding Co., Ltd. authorizes a Buyback Plan. | CI |
1st Jan change | Capi. | |
---|---|---|
-72.78% | 135M | |
+35.58% | 16.48B | |
+37.29% | 5.14B | |
+11.70% | 4.54B | |
-7.50% | 4.45B | |
+31.67% | 4.44B | |
+25.05% | 4.4B | |
+9.50% | 4.05B | |
+61.80% | 3.03B | |
+71.03% | 2.35B |
- Stock Market
- Equities
- 002141 Stock
- News Infund Holding Co., Ltd.
- Chengdu Shiji Biopharmaceutical Co., Ltd. announced that it expects to receive CNY 60 million in funding from Liaoning Chengda Biotechnology Co.,Ltd., Infund Holding Co., Ltd.